학술논문

Real-world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first-line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma
Document Type
Article
Source
In: Asia-Pacific Journal of Clinical Oncology. (Asia-Pacific Journal of Clinical Oncology, October 2023, 19(5):e231-e238)
Subject
Language
English
ISSN
17437563
17437555